F. Arteaga et al., DISPARITY BETWEEN SEROLOGICAL REACTIVITY TO BORRELIA-BURGDORFERI AND EVIDENCE OF PAST DISEASE IN A HIGH-RISK GROUP, Clinical infectious diseases, 27(5), 1998, pp. 1210-1213
A prevalence study of past Lyme borreliosis in persons with outdoor oc
cupations was done. Consenting individuals (n = 302) were administered
a questionnaire eliciting demographic and occupational data and a cli
nical history, and were asked to donate a serum specimen for detection
of antibodies to Borrelia burgdorferi by enzyme-linked immunosorbent
assay (ELISA), immunoblotting, and borrelia inhibition assays, and for
detection of potentially cross-reactive antibodies. Of 302 individual
s, 77 (25%) had reactive antibodies detected by ELISA. Of these 302 in
dividuals, 44 (15%) met the criteria of the Centers for Disease Contro
l and Prevention for serological reactivity as evidenced by immunoblot
ting, and 70 (23%) had inhibitory activity. Through the clinical crite
ria employed, only 11 individuals with serological reactivity had prio
r illness compatible with Lyme borreliosis. Higher ELISA absorbances w
ere positively correlated with age and duration of outdoor occupation.
The results from three serological assays and the lack of reactivity
to potentially crossreactive infectious agents indicate that serologic
al reactivity was due to exposure to B. burgdorferi. The disparity bet
ween serological reactivity and the clinical evidence of Lyme borrelio
sis suggests cumulative exposure to a nonpathogenic form of B. burgdor
feri.